Omega Diagnostics Group PLC also announced that Bill Rhodes, Non-Executive Director, has notified the Board that he will also step down from his role at the end of February 2022. The Company will begin the process of seeking suitable Non-Executive Director candidates.
Cambridge Nutritional Sciences plc
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.25 GBX | +2.41% | +2.41% | +77.08% |
24/05 | Cambridge Nutritional Sciences appoints James Copper as COO | AN |
24/05 | Cambridge Nutritional Sciences Names COO | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+77.08% | 12.56M | |
-4.22% | 12.45B | |
-0.60% | 8.22B | |
+6.61% | 5.72B | |
-10.21% | 4.11B | |
-60.50% | 2.68B | |
+10.62% | 2.68B | |
-5.50% | 2.37B | |
+16.30% | 2.06B | |
-9.18% | 1.8B |
- Stock Market
- Equities
- ODX Stock
- News Cambridge Nutritional Sciences plc
- Bill Rhodes to Step Down as Non-Executive Director from Omega Diagnostics Group PLC